HEMISPHERIAN AS
925333409ActiveDeveloping novel small molecule drugs targeting TET2 for aggressive cancers.
Yleiskatsaus
- 5
- Työntekijät
- 269t NOK
- Liikevaihto
- 2020
- Perustettu
Avainpäättäjät
Zeno Albisser
Chief Executive Officer
Wolfram Eichner
Director
Adam Robertson
Chief Scientific Officer
Terezia Prikrylova
Chief Operating Officer
+15 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Hemispherian is an innovative preclinical pharmaceutical company dedicated to redefining targeted cancer therapeutics. The core focus is developing a novel class of small molecule drugs that specifically target the TET2 enzyme. These compounds are designed as targeted therapies for particularly aggr...
Tunnisteet
Avainsanat
Teknologiat
Yritystiedot
- Toimiala
- Tuntematon
- Oikeudellinen muoto
- Aksjeselskap
- ALV-numero
- Tuntematon
Päättäjät
19 yhteystietoa FunnelfeedrissäZeno Albisser
Chief Executive Officer
Wolfram Eichner
Director
Adam Robertson
Chief Scientific Officer
Terezia Prikrylova
Chief Operating Officer
Roger Stupp
Chair of Clinical Advisory Board
Michael Lim
Clinical Advisory Board Member
Monika Hegi
Clinical Advisory Board Member
Paul Lelieveld
Chairman
Frode Vartdal
Director
Dallas Hack
Director
Peter Suenaert
Chief Medical Officer
Einar O. Vik-Mo
Clinical Advisory Board Member
Isabelle M. Germano
Clinical Advisory Board Member
Anna Koptina
Head of Regulatory Affairs
Marek Cichocki
Director Chemistry, Manufacturing and Control
Muut yhteyshenkilöt
Sandra Cantilena
Senior Scientist
Josipa Matic
Medicinal Chemist (H2020 Funded)
Guro Kristoffersen
Scientist
Frans van Dalen
Observer
Samankaltaiset yritykset
20 samankaltaista yritystä Funnelfeedrissä
One-carbon Therapeutics AB
Clinical-stage biotech pioneering novel anti-cancer therapies targeting metabolism.
ONCOSYNE AS
6 työntekijätDeveloping cancer treatments using patient-derived 3D tumoroid models.
Double Bond Pharmaceutical AB
5–9 työntekijätDeveloping advanced drug delivery systems for targeted cancer and pneumonia treatment.
OSLO SCIENCE HUB AS
Accelerating cancer treatment development through collaboration and innovation.
EXACT THERAPEUTICS AS
12 työntekijätClinical-stage company developing ultrasound-mediated targeted therapy enhancement.
Selaa lisää
Kysymyksiä yrityksestä HEMISPHERIAN AS
Haluatko nähdä Funnelfeedrin toiminnassa?
Varaa ilmainen demo ja tutustu siihen, miten Funnelfeedr auttaa sinua löytämään ja konvertoimaan ihanteelliset asiakkaasi.
Varaa demo